CTCFL regulates the PI3K-Akt pathway and it is a target for personalized ovarian cancer therapy
| Image |  |
|---|---|
| Description | scientific article published on 07 February 2022 |
| Author/s |
author: Ernesto Soto-Reyes Jan Baumbach |
| Publication date | February 7, 2022 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |